|
is a Founder of Novacea. Dr. Weber is a Partner at Domain Associates where he searches for novel drug products or technologies and founds biotechnology and biopharmaceutical start-up companies around those products or technologies. Dr. Weber actively manages, on an interim-basis, the companies he founds until permanent, full-time management has been recruited. Dr. Weber has been founding CEO of multiple biopharmaceutical companies in the Domain portfolio including Cytovia, Acea Pharmaceuticals, Novacea, NovaCardia, Novalar Pharmaceuticals, Orexigen Therapeutics, Domain Antibacterial Acquisition Corporation, Ascenta Therapeutics, Konova, and Renovia. He currently serves as interim CEO of Tragara Pharmaceuticals and Syndax Pharmaceuticals, two seed-stage biopharmaceutical companies. He is Chairman of the Board at Novacea, NovaCardia, Cerexa, Orexigen, Novalar, Renovia and Ascenta. In addition, he is a board member of Conforma Therapeutics, DiObeX and Biovascular, Inc. Until 1995, Dr. Weber was a tenured Professor of Pharmacology at the University of California at Irvine. He has over 20 years of drug discovery and development experience and has been a consultant to biotechnology and pharmaceutical companies. He is the inventor or co-inventor of over 40 patents and patent applications, and he has published over 130 papers in scientific periodicals. | 